AptarGroup, Inc.

Equities

ATR

US0383361039

Real-time Estimate Cboe BZX Other stock markets 15:09:52 2026-01-22 EST			5-day change	1st Jan Change
124.50 ^USD	-0.40%		-0.55%	+2.02%

01-14	AptarGroup, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 08:15 AM
01-13	Aptar Group, Inc.'S Nasal Vaccine Delivery Solutions Featured in Castlevax Phase II Clinical Trial of an Intranasal Covid-19 Vaccine Candidate	CI

Transcript : AptarGroup, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 12

Published on 11/19/2025 at 08:06 am EST - Modified on 11/19/2025 at 08:51 am EST

S&P Capital IQ

Presenter Speech
Daniel Rizzo (Analysts)

Good afternoon. I am Dan Rizzo with Jefferies Equity Research. Up next, we have Aptar Group. And today with us today, we have CEO, Stephan Tanda; CFO, Vanessa

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about AptarGroup, Inc.

01-14	AptarGroup, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 08:15 AM
01-13	Aptar Group, Inc.'S Nasal Vaccine Delivery Solutions Featured in Castlevax Phase II Clinical Trial of an Intranasal Covid-19 Vaccine Candidate	CI
01-12	AptarGroup, Inc. Announces Newest Technology, Beat the Blink??	CI
01-06	AptarGroup Shares Fall After Wells Fargo Downgrade	MT
01-06	Wells Fargo Downgrades AptarGroup to Equalweight From Overweight, Price Target is $133	MT
12-17	Aptar Group, Inc.'s Bidose Nasal System Delivers Cardymst?? Nasal Spray for Paroxysmal Supraventricular Tachycardia	CI
12-16	AptarGroup Insider Sold Shares Worth $1,818,435, According to a Recent SEC Filing	MT
12-01	AptarGroup Acquires Brazil-Based Sommaplast	MT
11-30	AptarGroup, Inc. completed the acquisition of Sommaplast Industria e Comercio Ltda from the family.	CI
11-19	AptarGroup, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 12:00 PM
11-17	AptarGroup Inc files for senior notes offering, size not disclosed - SEC filing	RE
11-03	AptarGroup Shares Fall After William Blair Downgrade	MT
11-03	William Blair Downgrades AptarGroup to Market Perform From Outperform	MT
25-10-31	AptarGroup Shares Decline After Issuing Q4 Adjusted Earnings Guidance Below Expectations	MT
25-10-31	AptarGroup, Inc., Q3 2025 Earnings Call, Oct 31, 2025
25-10-31	Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on October 10, 2024.	CI
25-10-31	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Big Tech Earnings Reignite Market Momentum	MT
25-10-31	AptarGroup Q3 Non-GAAP Earnings, Revenue Rise; Q4 Non-GAAP Earnings Guidance Issued	MT
25-10-30	AptarGroup, Inc. entered into an agreement to purchase to acquire Sommaplast Industria e Comercio Ltda from the family for $35 million.	CI
25-10-30	AptarGroup beats Q3 sales expectations	RE
25-10-30	(ATR) AptarGroup, Inc. Expects Q4 Adjusted EPS Range $1.20 - $1.28	MT
25-10-30	Earnings Flash (ATR) AptarGroup, Inc. Reports Q3 Revenue $961.1M, vs. FactSet Est of $951.9M	MT
25-10-30	Earnings Flash (ATR) AptarGroup, Inc. Posts Q3 Adjusted EPS $1.62 per Share, vs. FactSet Est of $1.57	MT
25-10-30	AptarGroup, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-16	AptarGroup Division Says It Gets US FDA 510K Clearance for HeroTracker Sense as Class 2 Medical Device	MT